Navigation Links
Neurognostics pushes early prediction of brain disease

Milwaukee Score one for early prediction: Neurognostics, a firm in Milwaukee that develops devices for magnetic resonance imaging (MRI), has made strides since its founding two years ago toward the treatment of disorders before any physical signs develop.

"MRI is the most popular and useful mapping technique in the world ... in research," said Steve Rao, founder and chief science ......

Full article >>> no to study their drug Aricept, using MRI to analyze how effective it was in treating patients with multiple sclerosis. Tucker said Neurognostics is in the middle of negotiations with two other firms for similar projects.

"We assist the pharmaceutical company in making go or no go solutions, and we can do this by showing it's more sensitive then paper-pencil tests," Rao said.

......

Full article >>> mpany is trying to find new sites that have limited experience with functional MRI so they can learn how it operates in a neutral environment.

"We're hitting the pavement finding implementation sites," Tucker said.

Tucker said the company also plans to build off a Phase I Small Business Innovation Research grant the company received in October from the National Institutes of Heal......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 03/16/05


Related biology technology :

1. Neurognostics to partner with Racine distributor
2. Neurognostics partners with Medical Numerics
3. Neurognostics recognized for MRI award
4. Neurognostics receives special FDA clearance for MindState fDAD
5. Neurognostics receives award for MRI innovation
6. Silva-Craig joins Neurognostics board
7. Wisconsin pushes for adoption of electronic health records
8. Biotech Alliance pushes ahead in SE Wisconsin with likely state funding
9. Rapid hit confirmation and early hERG liability testing using the IonWorks HT system
10. Venture Investors early-stage fund grows to $115 million
11. GE acquisition may boost "early" healthcare strategy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... San Diego, CA (PRWEB) , ... June 27, 2016 , ... ... mClinical solutions for clinical trials, announced today the Clinical Reach Virtual Patient ... and their care circle with the physician and clinical trial team. , Using the ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
Breaking Biology Technology:
(Date:6/9/2016)... June 9, 2016 Paris ... Teleste,s video security solution to ensure the safety of people ... during the major tournament Teleste, an international ... and services, announced today that its video security solution will ... to back up public safety across the country. The system ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
Breaking Biology News(10 mins):